Exciting progress in breast cancer treatment emerged in 2024, with hyperthermia—a heat-based therapy—gaining momentum as an innovative adjuvant approach. Research and clinical trials last year highlighted its potential to enhance the effectiveness of radiation and chemotherapy, particularly for locally advanced and recurrent cases. A standout development came from Amrita Hospital and IIT Hyderabad, who secured a grant to develop a robotic ultrasound system for precise tumor targeting and motion tracking during hyperthermia delivery. Meanwhile, SBI General Insurance partnered with IIT Madras to create a thermal therapy device, boosting outcomes for breast cancer patients alongside traditional treatments. These advancements underscore hyperthermia’s growing role in personalized, non-invasive care—offering hope for improved tumor control and patient quality of life.

#ThermoOncology #BreastCancer #Hyperthermia #CancerResearch